TRIAL OF AN ATTENUATED BOVINE ROTAVIRUS VACCINE (RIT 4237)
暂无分享，去创建一个
[1] R. Chanock,et al. Independent segregation of two antigenic specificities (VP3 and VP7) involved in neutralization of rotavirus infectivity. , 1985, Proceedings of the National Academy of Sciences of the United States of America.
[2] G. Beards,et al. Clinical efficacy of the RIT 4237 live attenuated bovine rotavirus vaccine in infants vaccinated before a rotavirus epidemic. , 1985, The Journal of pediatrics.
[3] A. Herring,et al. Bovine rotavirus serotypes and their significance for immunization , 1984, Journal of clinical microbiology.
[4] G. Zissis,et al. PROTECTION OF INFANTS AGAINST ROTAVIRUS DIARRHOEA BY RIT 4237 ATTENUATED BOVINE ROTAVIRUS STRAIN VACCINE , 1984, The Lancet.
[5] H. Greenberg,et al. Serotypic similarity and diversity of rotaviruses of mammalian and avian origin as studied by plaque-reduction neutralization. , 1984, The Journal of infectious diseases.
[6] G. Zissis,et al. IMMUNOGENICITY AND SAFETY OF LIVE ORAL ATTENUATED BOVINE ROTAVIRUS VACCINE STRAIN RIT 4237 IN ADULTS AND YOUNG CHILDREN , 1983, The Lancet.
[7] H. Greenberg,et al. Serological analysis of the subgroup protein of rotavirus, using monoclonal antibodies , 1983, Infection and immunity.